Delivery Order SPE2DB22D1202-SPE2DB24FUUH8
- Not listed
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has an ultimate completion date of August 25, 2023 and a ceiling value of $1,016.24. This order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical company. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, 120 ml, with a potential value of $1,270.30 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, with a potential value of $3,048.72 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, for the supply of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension 120 ml. The contract has a ceiling value of $9,561.40 and a period of performance through March 13, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a leading global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. The delivery order, valued at $6,340.16, has a firm fixed price and a performance period through July 18, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. The $1,445.62 firm fixed price contract has a completion date of November 21, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles, with a ceiling value of $1,492.11 and a period of performance through March 6, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has a ceiling value of $1,051.36 and runs through January 22, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,314.20, is a delivery order for the supply of Quillivant XR 25 mg/5 ml suspension medication. It is a firm fixed-price contract with a period of performance ending on December 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication, with a ceiling value of $1,015.19 and a performance period through April 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUUH8Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award, with a ceiling value of $1,270.30 and a completion date of March 21, 2024, is for the supply of Quillivant XR 25 mg/5 ml suspension medication. The contract is part of AmerisourceBergen Drug Corp's broader role as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide pharmaceuticals and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. No set-aside designation was used for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/20/24 |